Canopy Growth (CGC) vs Cronos Group (CRON)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cronos Group (CRON) has outperformed Canopy Growth (CGC) over the past year, gaining 23.7% versus a loss of 39.6%. Over five years, CRON leads with a -40.9% price change compared with -99.3% for CGC. Cronos Group is the larger company by market cap ($1.19 billion vs $393.8 million), about 3.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CGC | CRON |
|---|---|---|
| Share price | $0.8765 | $3.24 |
| Market cap | $393.81M | $1.19B |
| 1-day change | -1.59% | -1.37% |
| YTD return | -23.11% | +23.19% |
| 1-year return | -39.55% | +23.66% |
| 5-year return | -99.34% | -40.88% |
| P/E ratio (TTM) | — | 17.05 |
| EPS (TTM) | $-0.45 | $0.19 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.38 | $3.61 |
| 52-week low | $0.844 | $2.28 |
| Distance from 52-week high | -63.17% | -10.20% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +35.77% | -24.07% |
| Average volume | 2.77M | 1.14M |
| Shares outstanding | 423.04M | 368.41M |
| Employees | 1,128 | 610 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cronos Group is about 3.0 times larger than Canopy Growth by market value ($1.19B vs $393.81M).
- CRON has outperformed CGC by 63.2 percentage points over the past year.
About Canopy Growth
CGC stock →Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel.
Health Care · Medicinal Chemicals and Botanical Products · 1,128 employees
About Cronos Group
CRON stock →Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names.
Health Care · Medicinal Chemicals and Botanical Products · 610 employees
CGC vs CRON FAQ
Which is bigger, Canopy Growth or Cronos Group?
Cronos Group (CRON) is larger, with a market capitalization of $1.19B compared with $393.81M for Canopy Growth (CGC).
Which stock has performed better over the past year, CGC or CRON?
CRON returned +23.66% over the past 12 months, compared with -39.55% for CGC (price return, excluding dividends). Past performance does not predict future results.
Are Canopy Growth and Cronos Group in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.